Purpose
To provide an end-to-end immunogen production service using Messenger RNA (mRNA) technology for grantees of the Foundation who are evaluating novel vaccine candidates intended for low/middle income country populations
Grantee
Division
Gender Equality,
Global Health
Date
NOVEMBER 2023
Region served
GLOBAL
Committed amount
$2,606,382
Grant topic
Discovery and Translational Sciences,
Empower Women and Girls,
Enterics, Diagnostics, Genomics & Epidemiology,
HIV,
Malaria,
Maternal, Newborn, Child Nutrition and Health,
Neglected Tropical Diseases,
Pneumonia & Pandemic Preparedness,
Tuberculosis,
Vaccine Development
Duration (months)
46
Grantee location
Seattle, Washington, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.